Halberstadt, AL. Pharmacology and Toxicology of N-Benzylphenethylamine (“NBOMe”) Hallucinogens In Neuropharmacology of New Psychoactive Substances (NPS): The Science Behind the Headlines; Halberstadt, AL; Vollenweider, FX; Nichols, DE, Eds., Springer, 18 Jan 2017; pp 283-311. 826 kB. https://doi.org/10.1007/7854_2016_64
Leth-Petersen, S; Gabel-Jensen, C; Gillings, N; Lehel, S; Hansen, HD; Knudsen, GM; Kristensen, JL. Metabolic fate of hallucinogenic NBOMes Chem. Res. Toxicol., 19 Jan 2016, 29 (1), 96–100. 951 kB. https://doi.org/10.1021/acs.chemrestox.5b00450 #5, 15 (SI) See also Supporting information LC,NMR
Poulie, CBM; Jensen, AA; Halberstadt, AL; Kristensen, JL. DARK Classics in Chemical Neuroscience: NBOMes ACS Chem. Neurosci., 2 Dec 2020, 11 (23), 3860-3869. 860 kB. https://doi.org/10.1021/acschemneuro.9b00528 #5
25B-NBOH · 2C-B-NBOH · N-(2-Hydroxybenzyl)-4-bromo-2,5-dimethoxyphenethylamine
25B-NB3OH · N-(3-Hydroxybenzyl)-4-bromo-2,5-dimethoxyphenethylamine
25H-NB5Br2OH · 25H-NBOH5Br · N-(5-Bromo-2-hydroxybenzyl)-2,5-dimethoxyphenethylamine
5-DM-25B-NBOMe · N-(2-Methoxybenzyl)-4-bromo-5-hydroxy-2-methoxyphenethylamine